Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
The possibility that hypersecretion of corticotropin-releasing factor (CRF) contributes to the hyperactivity of the hypothalamo-pituitary-adrenal axis observed in patients with major depression was investigated by measuring the concentration of this peptide in cerebrospinal fluid of normal healthy volunteers and in drug-free patients with DSM-III diagnoses of major depression, schizophrenia, or dementia. When compared to the controls and the other diagnostic groups, the patients with major depression showed significantly increased cerebrospinal fluid concentrations of CRF-like immunoreactivity; in 11 of the 23 depressed patients this immunoreactivity was greater than the highest value in the normal controls. These findings are concordant with the hypothesis that CRF hypersecretion is, at least in part, responsible for the hyperactivity of the hypothalamo-pituitary-adrenal axis characteristic of major depression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HPA alterations correlate with impaired cognitive function 66,67 in depressed patients”
From Major depressive disorder (2016) · cites this paper as [67]
In the citing paper
“elevated basal cerebrospinal fluid CRH levels”
From Glucocorticoids, cytokines and brain abnormalities in depression (2011) · cites this paper as Nemeroff et al., 1984
Citations
Cites
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965
Self-citationVALE, W., SPIESS, J., RIVIER, C., & RIVIER, J. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198205000-00013 · Cited by 3,904
Self-citationCarroll, B. J. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780260017001 · Cited by 2,243
Disrupted 24-hour patterns of cortisol secretion in psychotic depression
Sachar, E. J. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.01750310011002 · Cited by 775
Corticotropin-Releasing Factor: Actions on the Sympathetic Nervous System and Metabolism*
BROWN, M. R., FISHER, L. A., SPIESS, J., RIVIER, C., RIVIER, J., & VALE, W. (1982) · Endocrinology · doi:10.1210/endo-111-3-928 · Cited by 651
Self-citationNeuroendocrine Regulation in Depression: II. Discrimination of Depressed From Nondepressed Patients
Carroll, B. J. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770090041003 · Cited by 627
Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty
Britton, D. R., Koob, G. F., Rivier, J., & Vale, M. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90416-7 · Cited by 534
Psychiatric implications of basic and clinical studies with corticotropin-releasing factor
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.5.619 · Cited by 481
Corticotropin releasing factor (CRF): immunoreactive neurones and fibers in rat hypothalamus
Bloom, F. E., Battenberg, E. L. F., Rivier, J., & Vale, W. (1982) · Regulatory Peptides · doi:10.1016/0167-0115(82)90107-0 · Cited by 364
Self-citationGreden, J. F. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790050019002 · Cited by 358
Research works printed but not linked: 6
- Carroll, B. J., Handbook on Depression: 325 (1977).
- FISHMAN, A.J., PEPTIDES 1: 149 (1982).
- Rivier, J., Proceedings of the National Academy of Sciences of the United States of America 80: 4851 (1983).
- SNEDECOR, G.W., STAT METHODS: 271 (1967).
- SOKAL, R.R., BIOMETRY: 391 (1969).
- WHYBROW, P.C., MOOD DISORDERS NEW P: 1 (1984).
Cited by
Items 401–500 of 1,001
Corticotropin-Releasing Factor (CRF) circuit modulation of cognition and motivation
Hupalo, S., Bryce, C. A., Bangasser, D. A., Berridge, C. W., Valentino, R. J., & Floresco, S. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.06.010 · Cited by 103
“Perturbations in cost/ benefit decision-making are observed in stress-related psychiatric illnesses associated with CRF hypersecretion (Nemeroff et al., 1984; Treadway et al., 2012).”
BackgroundDexamethasone suppresses pituitary-adrenal but not behavioral effects of centrally administered CRF
Britton, D. R., Varela, M. F., García, A., & Rosenthal, M. J. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90305-x · Cited by 99
Corticotropin-releasing hormone and the hypothalamic–pituitary–adrenal axis in psychiatric disease
Naughton, M., Dinan, T. G., & Scott, L. V. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-59602-4.00005-8 · Cited by 107
Stress and the brain: Solving the puzzle using microdialysis
Linthorst, A. C. E., & Reul, J. M. H. M. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.09.019 · Cited by 106
Third‐generation antidepressants
Pinder, R. M., & Wieringa, J. H. (1993) · Medicinal Research Reviews · doi:10.1002/med.2610130304 · Cited by 108
CRF signaling: molecular specificity for drug targeting in the CNS
ARZT, E. S., & Holsboer, F. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.08.007 · Cited by 106
Wilkinson, P. O., & Goodyer, I. M. (2011) · Development and Psychopathology · doi:10.1017/s0954579411000472 · Cited by 86
“Some studies have demonstrated that CSF CRH is higher in patients with depressive disorder than comparison subjects with other psychiatric disorders or no disorders (Banki, Bissette, Arato, O'Connor, & Nemeroff, 1987; Nemeroff et al., 1984).”
BackgroundOpp, M. R. (1995) · Advances in Neuroimmunology · doi:10.1016/0960-5428(95)00004-l · Cited by 97
Role of Corticotropin‐Releasing Factor Receptor‐1 in Opiate Withdrawal
Iredale, P. A., Alvaro, J. D., Lee, Y., Terwilliger, R., Chen, Y. L., & Duman, R. S. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0740199.x · Cited by 96
Berridge, C. W., & Dunn, A. J. (1986) · Regulatory Peptides · doi:10.1016/0167-0115(86)90196-5 · Cited by 101
Amsterdam, J. D. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800210019003 · Cited by 97
Depression and antidepressants: molecular and cellular aspects
Lanni, C., Govoni, S. M., Lucchelli, A., & Boselli, C. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0055-x · Cited by 107
“Elevated concentrations of CRF in CSF of drug-free patients with MDD and from suicide victims compared with patients with other psychiatric disorders and healthy controls have been reported [113, 114].”
BackgroundGlucocorticoid receptors, fibromyalgia and low back pain
Lentjes, E. G. W. M., Griep, E. N., Boersma, J. W., Romijn, F. P. H. T. M., & de Kloet, E. R. (1997) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(97)00061-9 · Cited by 96
Modeling treatment-resistant depression
Samuels, B. A., Leonardo, E. D., Gadient, R., Williams, A., Zhou, J., David, D. J., Gardier, A. M., Wong, E. H. F., & Hen, R. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.02.017 · Cited by 87
“…axis, and stress generally leads to hypersecretion of corticosteroids, which imposes an increased risk for depression (Antonijevic, 2006; Brown et al., 2004; Carroll et al., 1981; de Kloet et al., 2005; Leonardo and Hen, 2006; Nemeroff et al., 1984; Sachar et al., 1970; Strohle and Holsboer, 2003).”
CRH, Stress, and Major Depression: A Psychobiological Interplay
Claes, S. J. (2004) · Vitamins and hormones · doi:10.1016/s0083-6729(04)69005-4 · Cited by 110
Mizoguchi, K., Shoji, H., Ikeda, R., Tanaka, Y., & Tabira, T. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.07.002 · Cited by 104
Calfa, G., Kademian, S., Ceschin, D., Vega, G., Rabinovich, G. A., & Volosin, M. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00051-3 · Cited by 97
“In fact, in patients with depression an increased concentration of CRH in cerebrospinal fluid, a blunted ACTH response to a CRH challenge and downregulation of CRH receptors were found in post-mortem frontal cortices of suicide victims (Nemeroff et al., 1984; Plotsky et al., 1995; Holsboer and Barden, 1996; Deuschle e…”
BackgroundDunn, A. J., & Swiergiel, A. H. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.069 · Cited by 106
“Many depressed patients also exhibit elevated CSF concentrations of CRF (Nemeroff et al., 1984; Arborelius et al., 1999, however, some depressed patients have lower or unchanged concentrations (Roy et al., 1987; France et al., 1988; Molchan et al., 1993).”
BackgroundEhlers, C. L., & Kupfer, D. J. (1987) · Biological Psychiatry · doi:10.1016/0006-3223(87)90173-9 · Cited by 94
Evidence for the role of corticotropin-releasing factor in major depressive disorder
Waters, R. P., Rivalan, M., Bangasser, D. A., Deussing, J. M., Ising, M., Wood, S. K., Holsboer, F., & Summers, C. H. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.07.011 · Cited by 93
“…modulators of stress responsiveness, including CRF (Goldstein and Klein, 2014; Ising et al., 2007); during clinical depression elevated CRF concentrations are measured in plasma (Galard et al., 2002) and cerebrospinal fluid (Banki et al., 1987; Hartline et al., 1996; Nemeroff et al., 1984).”
BackgroundMethodLong-Term Regulation of Locus Ceruleus Sensitivity to Corticotropin-Releasing Factor by Swim Stress
Curtis, A. L., Pavcovich, L. A., & Valentino, R. J. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38261-8 · Cited by 91
Functional interactions between steroid hormones and neurotrophin BDNF
Numakawa, T., Yokomaku, D., Richards, M., Hori, H., Adachi, N., & Kunugi, H. (2010) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v1.i5.133 · Cited by 98
17β-Estradiol Differentially Regulates Stress Circuitry Activity in Healthy and Depressed Women
Jacobs, E. G., Holsen, L. M., Lancaster, K., Makris, N., Whitfield-Gabrieli, S., Remington, A., Weiss, B. K., Buka, S. L., Klibanski, A., & Goldstein, J. M. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.203 · Cited by 99
“A long history of clinical evidence implicates HPA- and HPG-axis dysregulation in the development of mood disorders (Plotsky et al, 1998; Young and Korszun, 2002; Nemeroff et al, 1984).”
BackgroundCerebrospinal Fluid Vasopressin, Oxytocin, sopressin, Oxytoc in Alzheimer's Diseasβ-Endorphin
Raskind, M. A. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800040092013 · Cited by 91
Matsuzaki, I., Takamatsu, Y., & Moroji, T. (1989) · Neuropeptides · doi:10.1016/0143-4179(89)90085-1 · Cited by 92
Neurobehavior Related to Epigenetic Differences in Preterm Infants
Lester, B. M., Marsit, C. J., Giarraputo, J., Hawes, K., LaGasse, L. L., & Padbury, J. F. (2015) · Epigenomics · doi:10.2217/epi.15.63 · Cited by 90
Stress-Related Immune Markers in Depression: Implications for Treatment
Hughes, M. M., Connor, T. J., & Harkin, A. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw001 · Cited by 85
“Evidence suggests that inflammation is associated with depression in certain subgroups of patients and that those who have experienced stressful life events such as childhood trauma or bereavement may be at greater risk of developing depression.”
BackgroundChanges in the immune system in depression and dementia: causal or co‐incidental effects?
Leonard, B. E. (2001) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(01)00014-4 · Cited by 91
Sasaki, A., Shinkawa, O., & Yoshinaga, K. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114390 · Cited by 93
Fossey, M. D., Lydiard, R. B., Ballenger, J. C., Laraia, M. T., Bissette, G., & Nemeroff, C. B. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00197-2 · Cited by 90
Self-citationMarcinkiewcz, C. A., Prado, M. M., Isaac, S. K., Marshall, A., Rylkova, D., & Bruijnzeel, A. W. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.231 · Cited by 87
“Clinical studies indicate that brain corticotropin-releasing factor (CRF) systems are hyperactive in patients with depressive disorders (Nemeroff et al, 1984; Zobel et al, 2000).”
BackgroundArborelius, L., Hawks, B. W., Owens, M. J., Plotsky, P. M., & Nemeroff, C. B. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1883-x · Cited by 100
“Notably, similar changes in central CRFergic systems have been observed in untreated, depressed patients (Arborelius et al. 1999a; Nemeroff et al. 1984; Raadsheer et al. 1994, 1995).”
Self-citationCerebrospinal fluid neuropeptides in mood disorder and dementia
Bánki, C. M., Karmacsi, L., Bissette, G., & Nemeroff, C. B. (1992) · Journal of Affective Disorders · doi:10.1016/0165-0327(92)90091-j · Cited by 90
Self-citationGlucocorticoids, Transmitters and Stress
Delbende, C., Delarue, C., Lefebvre, H., Bunel, D. T., Szafarczyk, A., Mocaër, E., Kamoun, A., Jégou, S., & Vaudry, H. (1992) · British Journal of Psychiatry · doi:10.1192/s0007125000296657 · Cited by 90
The brain-gut-microbiota interplay in depression: A key to design innovative therapeutic approaches
Varesi, A., Campagnoli, L. I. M., Chirumbolo, S., Candiano, B., Carrara, A., Ricevuti, G., Esposito, C., & Pascale, A. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106799 · Cited by 94
Rich-Edwards, J. W., Mohllajee, A. P., Kleinman, K., Hacker, M. R., Majzoub, J., Wright, R. J., & Gillman, M. W. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2535 · Cited by 88
“Maternal age, yr Younger than 25 40 (5) 4.”
BackgroundResultInfluentialStructural Changes in the Brain in Depression and Relationship to Symptom Recurrence
Bremner, J. D. (2002) · CNS Spectrums · doi:10.1017/s1092852900017442 · Cited by 86
Buwalda, B., de Boer, S. F., van Kalkeren, A. A., & Koolhaas, J. M. (1997) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(97)00032-2 · Cited by 102
“Based on the similarities between many of these short-lasting effects of centrally administered CRF and the behavioral signs and physiological symptoms that occur in human affective disorders, an important role for CRF in the pathophysiology of affective disorders was suggested (Nemeroff et al., 1984).”
BackgroundPitzalis, M. V., Iacoviello, M., Todarello, O., Fioretti, A. M., Guida, P., Massari, F., Mastropasqua, F., Russo, G. D., & RIZZON, P. (2001) · American Heart Journal · doi:10.1067/mhj.2001.114806 · Cited by 100
Are Essential Trace Elements Effective in Modulation of Mental Disorders? Update and Perspectives
Shayganfard, M. (2021) · Biological Trace Element Research · doi:10.1007/s12011-021-02733-y · Cited by 92
Optogenetic elevation of endogenous glucocorticoid level in larval zebrafish
De Marco, R. J., Groneberg, A. H., Yeh, C.-M., Castillo Ramírez, L. A., & Ryu, S. (2013) · Frontiers in Neural Circuits · doi:10.3389/fncir.2013.00082 · Cited by 86
“METHODS ARTICLE published: 06 May 2013 doi: 10.3389/fncir.2013.00082 Optogenetic elevation of endogenous glucocorticoid level in larval zebrafish”
BackgroundInfluentialDifferences of sympathetic and parasympathetic modulation in major depression
Schumann, A., Andrack, C., & Bär, K. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.07.009 · Cited by 91
Neuroendocrine Mechanisms and the Precipitation of Depression by Life Events
Checkley, S. (1992) · British Journal of Psychiatry · doi:10.1192/s0007125000296633 · Cited by 87
van Praag, H. M. (1996) · Psychiatry Research · doi:10.1016/s0165-1781(96)02923-x · Cited by 87
Chappell, P., Leckman, J., Goodman, W., Bissette, G., Pauls, D., Anderson, G., Riddle, M., Scahill, L., McDougle, C., & Cohen, D. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00221-9 · Cited by 85
Self-citationOwens, M. J., Bissette, G., & Nemeroff, C. B. (1989) · Synapse · doi:10.1002/syn.890040304 · Cited by 86
“We have found in several studies (Arato et al., 1986; Banki et al., 1987; Nemeroff et al., 1984) that the concentration of CRF is significantly increased in the CSF of drug-free depressed individuals.”
BackgroundSelf-citationα2-Adrenergic Receptor Function in Depression: The Cortisol Response to Yohimbine
Price, L. H. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800090035006 · Cited by 88
Sex-Biased Stress Signaling: The Corticotropin-Releasing Factor Receptor as a Model
Valentino, R. J., Bangasser, D. A., & Bockstaele, E. J. V. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.083550 · Cited by 90
Ruggiero, D. A., Underwood, M. D., Rice, P. M., Mann, J. J., & Arango, V. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00703-9 · Cited by 87
Kozicz, T., Ouwens, D. T. W. M., Faludi, G., Palkovits, M., & Roubos, E. W. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2007.12.050 · Cited by 93
Two Different Putative Genetic Animal Models of Childhood Depression
Malkesman, O., Braw, Y., Maayan, R., Weizman, A., Overstreet, D. H., Shabat-Simon, M., Kesner, Y., Touati-Werner, D., Yadid, G., & Weller, A. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.039 · Cited by 89
Effects of glucocorticoids on declarative memory function in major depression
Bremner, J. D., Vythilingam, M., Vermetten, E. H. G. J. M., Anderson, G. M., Newcomer, J. W., & Charney, D. S. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.10.020 · Cited by 91
Getting closer to affective disorders: the role of CRH receptor systems
Müller, M. B., & Wurst, W. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.06.007 · Cited by 94
Role of interleukin-1 in stress responses: A putative neurotransmitter
Shintani, F., Nakaki, T., Kanba, S., Kato, R., & Asai, M. (1995) · Molecular Neurobiology · doi:10.1007/bf02740837 · Cited by 99
The cortisol axis and psychiatric disorders: an updated review
George, M. Y., Mageed, S. S. A., Mansour, D. E., & Fawzi, S. F. (2025) · Pharmacological Reports · doi:10.1007/s43440-025-00782-x · Cited by 101
“CRF is broadly distributed in extrahypothalamic brain areas, where it works in conjunction with the hypo - thalamic CRF system as a neurotransmitter coordinating the behavioral, autonomic, endocrine, and immunological responses to stress [ 118 ].”
Schüle, C., Baghai, T. C., Eser, D., Häfner, S., Born, C., Herrmann, S., & Rupprecht, R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004324 · Cited by 83
“In depressed patients, elevated cortisol (COR) and adrenocorticotrophic hormone (ACTH) concentrations in the plasma [3–6] or in the cerebrospinal fluid (CSF) [7] have been found.”
BackgroundPsychosocial Factors and Coronary Calcium in Adults without Clinical Cardiovascular Disease
Roux, A. V. D., Ranjit, N., Powell, L. H., Jackson, S., Lewis, T. T., Shea, S., & Wu, C. O. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-11-200606060-00008 · Cited by 85
“It is plausible that some physiologic correlates of psychosocial stress, such as glucocorticoid levels (67) or inflammatory markers (11), generally are negatively associated with bone formation and calcification (11, 68–70) and could therefore be negatively associated with calcification of atherosclerotic plaques.”
Trevarthen, C., Aitken, K. J., Vandekerckhove, M., Delafield‐Butt, J., & Nagy, E. (2015) · Developmental Psychopathology · doi:10.1002/9780470939390.ch2 · Cited by 75
The pharmacological properties of antidepressants
Racagni, G., & Popoli, M. (2010) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3283311acd · Cited by 83
“…of circadian rhythmicity of cortisol and elevated concentrations of the neuropeptide corticotrophin-releasing factor (CRF) have also been reported (Nemeroff et al., 1984; Deuschle et al., 1997), and hypersecretion of cortisol in depression has been suggested to result in hippocampal volume loss,…”
BackgroundHodgson, R. A., Higgins, G. A., Guthrie, D. H., Lu, S. X., Pond, A. J., Mullins, D. E., Guzzi, M. F., Parker, E. M., & Varty, G. B. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.12.021 · Cited by 86
Endocannabinoid Signaling in the Etiology and Treatment of Major Depressive Illness
Hillard, C., & Liu, Q.-S. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660735 · Cited by 78
“For example, corticotropin releasing factor (CRF) concentrations are increased in the CSF of depressed patients compared to controls [137].”
BackgroundHPA-related CSF neuropeptides in suicide attempters
Träskman‐Bendz, L., Ekman, R., Regnéll, G., & Öhman, R. (1992) · European Neuropsychopharmacology · doi:10.1016/0924-977x(92)90018-4 · Cited by 89
Endocrinology and the brain: corticotropin-releasing hormone signaling
Inda, C., Armando, N. G., Claro, P. A. D. S., & Silberstein, S. (2017) · Endocrine Connections · doi:10.1530/ec-17-0111 · Cited by 89
Antidepressant-like activity of corticotropin-releasing factor type-1 receptor antagonists in mice
Nielsen, D. M., Carey, G. J., & Gold, L. H. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.091 · Cited by 87
“CRF (Catalan et al., 1998; Galard et al., 2002; Nemeroff et al., 1984).”
Daly, R. C., Su, T.-P., Schmidt, P. J., Pickar, D., Murphy, D. L., & Rubinow, D. R. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.2.172 · Cited by 81
Depression, anxiety, and the cardiovascular system: the cardiologist's perspective.
Sheps, D. S., & Sheffield, D. (2001) · PubMed · Cited by 97
Beaulieu, S., Gagné, B., & Barden, N. (1988) · Molecular Endocrinology · doi:10.1210/mend-2-8-727 · Cited by 81
Taché, Y., & Brunnhuber, S. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1410.007 · Cited by 91
Hoyer, J., Burmann, I., Kieseler, M., Vollrath, F., Hellrung, L., Arélin, K., Roggenhofer, E., Villringer, A., & Sacher, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059780 · Cited by 87
“Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis has been demonstrated in major depressive disorder and has been speculated to have an important role in the induction of sadness and impaired mood regulation [22,23].”
BackgroundSex-specific cell signaling: the corticotropin-releasing factor receptor model
Valentino, R. J., Van Bockstaele, E., & Bangasser, D. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.06.004 · Cited by 78
Pitts, A. F., Samuelson, S. D., Meller, W. H., Bissette, G., Nemeroff, C. B., & Kathol, R. G. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(95)00229-a · Cited by 88
Self-citationAkana, S. F., & Dallman, M. F. (1997) · Endocrinology · doi:10.1210/endo.138.8.5291 · Cited by 79
Martignoni, E., Petraglia, F., Costa, A., Bono, G., Genazzani, A. R., & Nappi, G. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1990.tb00994.x · Cited by 80
Clinical pharmacology of anxiolytics and antidepressants: A psychopharmacological perspective
Nutt, D. J., & Glue, P. (1989) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(89)90006-5 · Cited by 82
Roy, A., Everett, D., Pickar, D., & Paul, S. M. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800160024005 · Cited by 82
Pizzimenti, C. L., & Lattal, K. M. (2015) · Genes, Brain and Behavior · doi:10.1111/gbb.12187 · Cited by 76
“This finding is consistent with other mood disorders, like depression, which is a component of/highly comorbid with PTSD, in which CRF is also elevated (Nemeroff et al. 1984).”
ResultGoldstein, J. M., Handa, R. J., & Tobet, S. A. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2013.12.001 · Cited by 77
“There is a long history of work characterizing the HPA system as central to understanding the development of MDD (Nemeroff et al., 1984; Holsboer et al., 1987; Plotsky et al., 1998; Arborelius et al., 1999; Heim et al., 2002; Parker et al., 2003; Raison and Miller, 2003; Barden, 2004; Swaab et al.,…”
InfluentialWood, S. K., McFadden, K. V., Grigoriadis, D., Bhatnagar, S., & Valentino, R. J. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2648-6 · Cited by 72
“While many systems are acutely activated during stress and contribute to a healthy, adaptive stress response, dysfunction of the hypothalamic–pituitary–adrenal (HPA) stress axis is thought to occur during depression (Checkley 1996; Gold and Chrousos 2002; Nemeroff et al. 1984; Raadsheer et al. 1994).”
Schlienger, R. G., & Meier, C. R. (2003) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200303030-00001 · Cited by 90
Kalin, N. H., Fox, A. S., Kovner, R., Riedel, M. K., Fekete, E. M., Roseboom, P. H., Tromp, D. P. M., Grabow, B. P., Olsen, M. E., Brodsky, E. K., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.01.010 · Cited by 77
“It is important to note that some, but not all, human studies demonstrate increased CSF CRH concentrations associated with depression and/or suicide (79) and postmortem analyses of suicide victims have revealed increased activity in brain CRH systems (80–84).”
Finnell, J. E., Muniz, B. L., Padi, A. R., Lombard, C. M., Moffitt, C. M., Wood, C. S., Wilson, L. B., Reagan, L. P., Wilson, M. A., & Wood, S. K. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.01.013 · Cited by 75
Neuropeptide abnormalities in anorexia nervosa
Kaye, W. H. (1996) · Psychiatry Research · doi:10.1016/0165-1781(96)02985-x · Cited by 79
Marcus, E., & Berry, E. M. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1998.tb06130.x · Cited by 79
Stress, antidepressant drugs, and the locus coeruleus
Brady, L. S. (1994) · Brain Research Bulletin · doi:10.1016/0361-9230(94)90168-6 · Cited by 86
Neurochemical abnormalities of anorexia nervosa and bulimia nervosa
(1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.8.963 · Cited by 78
Effects of chronic and acute stressors and CRF on depression-like behavior in mice
Swiergiel, A. H., Leskov, I. L., & Dunn, A. J. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.07.018 · Cited by 85
Cerebrospinal Fluid Biomarkers for Huntington’s Disease
Byrne, L. M., & Wild, E. J. (2016) · Journal of Huntington's Disease · doi:10.3233/jhd-160196 · Cited by 78
“…found that plasma elevations of clusterin were mirrored in CSF from 20 patients and 10 controls in the first report from a CSF collection with dedicated matched contemporaneous healthy controls from the general population, rather than from patients under investigation for other conditions [12].”
BackgroundDuncan, G. E., Knapp, D. J., Carson, S. W., & Breese, G. R. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37467-1 · Cited by 79
Corticotronpin-releasing hormone inhibits maternal behavior and induces pup-killing
Pedersen, C. A., Caldwell, J. D., McGuire, M., & Evans, D. L. (1991) · Life Sciences · doi:10.1016/0024-3205(91)90278-j · Cited by 78
Gully, D., Geslin, M., Serva, L., Fontaine, E., Roger, P., Lair, C., Darre, V., MARCY, C. H., Rouby, P.-E., Simiand, J., et al. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.1.322 · Cited by 81
“Thus, high levels of cerebrospinal fluid CRF and an increased number of CRF immunoreactive neurons in the hypothalamic paraventricular nucleus have been measured in patients with depressive disorders (Nemeroff et al., 1984).”
BackgroundNovel glucocorticoid and cAMP interactions on the CRH gene promoter
King, B. R., Smith, R., & Nicholson, R. C. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00218-6 · Cited by 86
Patki, G., Atrooz, F., Alkadhi, I., Solanki, N., & Salim, S. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2014.10.051 · Cited by 72
“Involvement of dopaminergic (DA) system in aggression is also known [10], and corticotropin-releasing factor (CRF) by regulation of central NE system [11], are also postulated to be involved.”
BackgroundDepression and Stimulant Dependence: Neurobiology and Pharmacotherapy
KOSTEN, T. R., MARKOU, A., & KOOB, G. F. (1998) · The Journal of Nervous & Mental Disease · doi:10.1097/00005053-199812000-00001 · Cited by 77
Widerlöv, E., Bissette, G., & Nemeroff, C. B. (1988) · Journal of Affective Disorders · doi:10.1016/0165-0327(88)90051-1 · Cited by 83
“However, recent evidence suggests that hypersecretion of a hypothalamic 41 amino acid peptide, corticotropin releasing factor (CRF), is at least partly responsible for this hyperactivity (Nemeroff et al., 1984; Widerliiv et al., 1984; Banki et al., 1987).”
BackgroundResultSelf-citationAdrenal Gland Enlargement in Major Depression
Phillips, J. J. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820220089012 · Cited by 77
Finnell, J. E., & Wood, S. K. (2016) · Neurobiology of Stress · doi:10.1016/j.ynstr.2016.04.001 · Cited by 67
Inducible cAMP Early Repressor (ICER) and Brain Functions
Borlikova, G. G., & Endo, S. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8072-1 · Cited by 82
“Decreased depression-like behavior in ICER-overexpressing rats [46] may, in part, result from reduced CRH production, as the overproduction of CRH is believed to contribute to depression [66, 67].”
BackgroundDepressive symptoms during pregnancy: Impact on neuroendocrine and neonatal outcomes
Marcus, S., Lopez, J. F., McDonough, S., MacKenzie, M. J., Flynn, H., Neal, C. R., Gahagan, S., Volling, B., Kaciroti, N., & Vazquez, D. M. (2011) · Infant Behavior and Development · doi:10.1016/j.infbeh.2010.07.002 · Cited by 75
“high levels of central nervous system (CNS) CRH (Nemeroff et al., 1984), and (3) alterations in the inhibition of the LHPA axis (Young, Haskett, Murphy-Weinberg, Watson, & Akil, 1991).”
BackgroundGrigoriadis, D. E. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.4.651 · Cited by 75
“Postmortem studies, although not completely in agreement, have suggested that the elevated levels of CRF in the CSF of depressed patients, coupled with the decreased CRF receptor binding in the frontal cortex of suicide victims, is evidence that the CRF system is hyperactive in this disorder [153,158,280,281].”
BackgroundPlasma corticotropin-releasing factor in depressive disorders
Catalán, R., Gallart, J. M., Castellanos, J. M., & Galard, R. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00539-8 · Cited by 81
Metadata
- Authors
- Nemeroff, C. B., Widerlöv, E., Bissette, G., Walléus, H., Karlsson, I., Eklund, K., Kilts, C. D., Loosen, P. T., & Vale, W.
- Affiliations
- Duke University (US)
- Uppsala University (SE)
- Duke Medical Center (US)
- University of Gothenburg (SE)
- Salk Institute for Biological Studies (US)
- Venue
- Science
- Published
- 1984-12-14
- Volume
- 226
- Issue
- 4680
- Pages
- 1342-1344
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1974253960
- Semantic Scholar
- 1a0f9dda77d66396db9247777d53158b0628b325
- Cited by
- 1,485
- References
- 29
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 16 · 2023: 16 · 2022: 14 · 2021: 20 · 2020: 26 · 2019: 27 · 2018: 21 · 2017: 34 · 2016: 36 · 2015: 34 · 2014: 46 · 2013: 39 · 2012: 37
- FWCI
- 12.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Keywords
- corticotropin-releasing factor, cerebrospinal fluid, major depressive disorder, hypothalamic-pituitary-adrenal axis, hypersecretion, schizophrenia, dementia
- MeSH terms
- Adult, Aged, Corticotropin-Releasing Hormone, Dementia, Depressive Disorder, Female, Humans, Male, Middle Aged, Radioimmunoassay, Schizophrenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.